Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion description "[Furthermore, ICV leptin injections were able to decrease neuropeptide Y (NPY) levels in the arcuate and paraventricular hypothalamic nuclei in both lean and genetically obese fa/fa rats, although a higher leptin dose was again needed in the obese group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion evidence source_evidence_literature NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion SIO_000772 8826985 NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion wasDerivedFrom befree-2016 NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion wasGeneratedBy ECO_0000203 NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.